Metraipolis › archive › dc_4ba8f172dd06

Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives — Europe PMC PMID:41689691

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41689691
DOI
10.1007/s12672-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-05T19:57:58.692Z
SHA-256 of the archived text
fffac2944ce681e2be7f99000f191701801f4a2f30e8724ac37e5c28688444f0
Stable URL of this page
https://metraipolis.com/documento/dc_4ba8f172dd06

How to cite

Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives — Europe PMC PMID:41689691 — Europe PMC (en), https://europepmc.org/article/MED/41689691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ba8f172dd06 (Metraipolis archive dc_4ba8f172dd06, sha256 fffac2944ce681e2be7f99000f191701801f4a2f30e8724ac37e5c28688444f0)
BibTeX
@misc{dc4ba8f172dd06,
  title = {Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives — Europe PMC PMID:41689691},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41689691},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ba8f172dd06; sha256 fffac2944ce681e2be7f99000f191701801f4a2f30e8724ac37e5c28688444f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41689691. Agents can read the archived copy with the MCP tool read_document.